89 related articles for article (PubMed ID: 3034405)
1. Causal role for an activated N-ras oncogene in the induction of tumorigenicity acquired by a human cell line.
Tainsky MA; Shamanski F; Blair D; Giovanella BC
Cancer Res; 1987 Jun; 47(12):3235-8. PubMed ID: 3034405
[TBL] [Abstract][Full Text] [Related]
2. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
[TBL] [Abstract][Full Text] [Related]
3. PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.
Tainsky MA; Krizman DB; Chiao PJ; Yim SO; Giovanella BC
Anticancer Res; 1988; 8(5A):899-913. PubMed ID: 3052262
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.
Chiao PJ; Kannan P; Yim SO; Krizman DB; Wu TA; Gallick GE; Tainsky MA
Oncogene; 1991 May; 6(5):713-20. PubMed ID: 1646984
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
7. Teratocarcinoma derived from mouse zygotes after the introduction of activated human c-Ha-ras DNA.
Katsuki M; Kimura M; Yokoyama M; Sato M; Kimura S; Hata J; Sekiya T; Izawa M; Nishimura S
Princess Takamatsu Symp; 1986; 17():269-76. PubMed ID: 3332015
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
9. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
10. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
[TBL] [Abstract][Full Text] [Related]
11. Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis.
Barrett JC; Oshimura M; Koi M
Symp Fundam Cancer Res; 1986; 39():45-56. PubMed ID: 3321309
[TBL] [Abstract][Full Text] [Related]
12. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.
Raybaud F; Noguchi T; Marics I; Adelaide J; Planche J; Batoz M; Aubert C; de Lapeyriere O; Birnbaum D
Cancer Res; 1988 Feb; 48(4):950-3. PubMed ID: 3276402
[TBL] [Abstract][Full Text] [Related]
13. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
Muschel RJ; Williams JE; Lowy DR; Liotta LA
Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
[TBL] [Abstract][Full Text] [Related]
14. Activation of N-ras gene in a rat hepatocellular carcinoma induced by dibutylnitrosamine and butylated hydroxytoluene.
Funato T; Yokota J; Sakamoto H; Kameya T; Fukushima S; Ito N; Terada M; Sugimura T
Jpn J Cancer Res; 1987 Jul; 78(7):689-94. PubMed ID: 3040652
[TBL] [Abstract][Full Text] [Related]
15. Activation of N-ras induced by ultraviolet irradiation in vitro.
Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
[TBL] [Abstract][Full Text] [Related]
16. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
Rosales C; Juliano R
Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
[TBL] [Abstract][Full Text] [Related]
17. Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cells.
Duménil D; Neel H; Lacout C; Dautry F
Exp Hematol; 1994 Feb; 22(2):178-85. PubMed ID: 8299738
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines.
Cooper CS; Blair DG; Oskarsson MK; Tainsky MA; Eader LA; Vande Woude GF
Cancer Res; 1984 Jan; 44(1):1-10. PubMed ID: 6418375
[TBL] [Abstract][Full Text] [Related]
19. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
20. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
